<!DOCTYPE html>
<html lang="en">
  
<!-- Mirrored from www.allindianpatents.com/patents/202962-a-process-for-the-preparation-of-novel-intermediate-of-moxifloxacin-therefor-and-production-method-of-the-intermediate by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 02:28:30 GMT -->
<!-- Added by HTTrack --><meta http-equiv="content-type" content="text/html;charset=utf-8" /><!-- /Added by HTTrack -->
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=Edge,chrome=1">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Indian Patents. 202962:A PROCESS FOR THE PREPARATION OF NOVEL INTERMEDIATE OF MOXIFLOXACIN THEREFOR AND PRODUCTION METHOD OF THE INTERMEDIATE</title>
    <meta content="authenticity_token" name="csrf-param" />
<meta content="cYcP52B8zyTWKbLwby2YPh9z/gvY/RLjWOwY4YXkiXg=" name="csrf-token" />

    <!-- Le HTML5 shim, for IE6-8 support of HTML elements -->
    <!--[if lt IE 9]>
      <script src="//cdnjs.cloudflare.com/ajax/libs/html5shiv/3.6.1/html5shiv.js" type="text/javascript"></script>
    <![endif]-->

    <link href="../assets/application-e80cf34975c5b1730c80b2f7170e7d26.css" media="all" rel="stylesheet" type="text/css" />

  </head>
  <body>

    <div class="navbar navbar-fluid-top">
      <div class="navbar-inner">
        <div class="container-fluid">
          <a class="btn btn-navbar" data-target=".nav-collapse" data-toggle="collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </a>
          <a class="brand" href="../index.html">Indian Patents</a>
          <div class="container-fluid nav-collapse">
            <ul class="nav">
              <li><a href="../recently-granted.html">Recently Granted Patents</a></li>
              <li><a href="../recently-published.html">Recently Published Patents</a></li>
            </ul>
            <form id="gform" class="navbar-search pull-right" action="https://www.google.com/search" method="get" target="_blank" onsubmit="document.getElementById('gform').q.value='site:http://www.allindianpatents.com '+document.getElementById('gform').q.value">
                <input type="text" name="q" id="q" class="search-query" placeholder="Search" onclick="this.value=''" autocomplete="off">
            </form>
          </div><!--/.nav-collapse -->
        </div>
      </div>
    </div>

    <div class="container-fluid">
      <div class="row-fluid">
        <div class="span12">

          <style>
          .allindianpatents-top { width: 320px; height: 50px; }
          @media(min-width: 500px) { .allindianpatents-top { width: 468px; height: 60px; } }
          @media(min-width: 800px) { .allindianpatents-top { width: 728px; height: 90px; } }
          </style>
          <center>
          </center>
          
          <div class="row-fluid">
	<div class="span8">

		<table class="table">
			<tr>
				<th>Title of Invention</th>
				<td><h1 style="font-size:large;">A PROCESS FOR THE PREPARATION OF NOVEL INTERMEDIATE OF MOXIFLOXACIN THEREFOR AND PRODUCTION METHOD OF THE INTERMEDIATE</h1></td>
			</tr>
			<tr>
				<th>Abstract</th>
				<td>The present invention relates to a process for the preparation of novel intermediate (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo [4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-l,4-dihydro-3-quinoline carboxylic acid-O3,O4)bis (acyloxy-O)borate by the reaction of ethyl l-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-l,4-dihydro-3- quinoline carboxylate with boric acid and acetic anhydride without using any catalyst gives (1-Cyclopropyl-6,7-difluoro-8-methoxy-4- oxo-l,4-dihydro-3-quinoline carboxylic acid-O3,O4)bis (acyloxy- O)borate which upon condensation in presence of a base(s) with (S,S)-2,8-diazabicyclo[4.3.0]nonane in organic polar solvent results the novel intermediate (4aS-Cis)-1-cyclopropyl-7-(2,8- diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro- 3-quinoline carboxylic acid-O3,O4)bis (acyloxy-O) borate.</td>
			</tr>
		</table>

					<style>
					.allindianpatents-post-abstract { width: 320px; height: 50px; }
					@media(min-width: 880px) { .allindianpatents-post-abstract { width: 468px; height: 60px; } }
					@media(min-width: 1267px) { .allindianpatents-post-abstract { width: 728px; height: 90px; } }
					</style>
					<center>
					<script async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script>
					<!-- AllIndianPatents-post-abstract -->
					<ins class="adsbygoogle allindianpatents-post-abstract"
					     style="display:inline-block"
					     data-ad-client="ca-pub-7914358224572760"
					     data-ad-slot="9152759240"></ins>
					<script>
					(adsbygoogle = window.adsbygoogle || []).push({});
					</script>					
					</center>

		<table class="table">
			<tr>
				<th>Full Text</th>
				<td> <br><br><br>
Field of the Invention: -<br>
The present invention relates to a novel intermediate, (4aS-Cis)-(1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis (acyloxy-O)borate and the process for its preparation<br>
Background of the Invention: -<br>
(4aS-CisH1-cyGlopropyl-7-(2,8-dia2abicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-0X0-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis (acyloxy-O)borate is an useful intermediate for the preparation of Moxifloxacin Hydrochloride namely (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-0X0-1,4-dihydro-3-quinoline carboxylic acid hydrochloride has the structure<br><br>
Moxifloxacin is a fluoroquinolone broad spectrum antibacterial particularly against gram-positive bacteria significantly better than those of Sparfloxacin and Ciprofloxacin that was disclosed in European patent no's EP 350,733 and EP 550,903. Moxifloxacin has activity against gram-negative and Gram-positive organisms, including Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, particularly against the respiratory disease-causing pathogens like Mycoplasma pneumonia, Mycobacterium tuberculosis. Chlamydia pneumoniae and the activity shown to be unaffected by B-lactamases.<br>
US Patent No 5,157,117 discloses (1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0 ,0 )bis (acyloxy-O)borate and a process for its preparation by reacting the ethyl 1-cyclopropyl-6 ,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylate with Boric acid and acetic<br><br>
anhydride in presence of zinc chloride and conversion to Gatifioxacin hydrochloride.<br>
European Patent No's EP 350,733, EP 550,903 &amp; EP 657,448 discloses preparation of Moxifloxacin by the condensation of 1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-quinoline carboxylic acid or its esters with (S,S) 2,8-Diaza bicyclo[4,3.0]nonane in presence of a base, followed by conversion to hydrochloride.<br>
It is a long felt of the industry to provide high yielding and cost effective process for the preparation of Moxifloxacin hydrochloride<br>
Summary of the invention: -<br>
The main object of the invention is to provide a process for the preparation of the novel intermediate (4aS-Cis)-1-cyclopropyl-7- (2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-clihydro-3-quinoline carboxylic acid-O^.C^jbis (acyloxy"0)borate.<br>
Another object of the invention is to provide a novel intermediate (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis (acyloxy-0) borate for its use in the preparation for moxifloxacin hydrochloride .<br>
Another object of the invention is to provide fingerprinting of the novel intermediate (4aS-Cis)-1-cyclopropyl"7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-O^,^^) bis (acyloxy-0) borate using NMR, IR and x-ray diffraction.<br>
Yet, another object of the invention is to provide a process for the preparation of (1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis (acyloxy-O)borate without using the catalyst and its use for the preparation of (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-O^.O'^jbis (acyloxy-O)borate.<br>
Accordingly, the present invention relates to a method for the preparation of novel intermediate (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo [4,3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-O^.O'^jbis (acyloxy-O)borate from the ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylate. The reaction of ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylate with boric acid and acetic anhydride without using any catalyst gives (1-Cyclopropyi-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis (acyloxy-0)borate which upon condensation in presence of a base(s) with (S,S)-2,8-diazabicyclo[4.3.0]nonane in organic polar solvent results the novel intermediate<br><br><br><br>
Brief description of the drawings: -<br>
Fig.1: X-ray diffraction pattern of the (4aS-Cis)-1"Cyclopropyl-7-(2,8"<br>
diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'*)bis (acyloxy-0) borate.<br>
Fig.2: FTIR spectrum of the (4aS-Cis)-1-cyclopropyl-7- (2,8-diazabicyclo [4.3.0] non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0 ,0'^)bis (acyloxy-O)borate.<br>
Fig.3: NMR spectrum of the (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo [4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'*)bis (acyloxy-O)borate.<br>
Detailed descripion of the Invention: -<br>
The process of the present invention comprises steps as:<br>
-	Reaction of Ethyl 1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylate with a mixture of boric acid and acetic anhydride   at temperature above 50*^C without the use of catalyst<br>
-	Separation of (1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxO"1,4-dihydro-3-quinoline carboxylic acid-0 ,0'^)bis (acyloxy-O)borate by cooling to low temperature followed by dilution with water<br><br>
-	Isolation and drying of the (1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4"dihydro-3-quinoline carboxylic acid-0 ,0'^)bis (acyloxy-O)borate<br>
-	Condensation of (1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis (acyloxy-O)borate with (S,S)-2,8-Diazabicyclo[4.3.0]nonane in presence of base(s) in organic polar solvent(s)<br>
-	Crystallization of (4aS-Cis)-1 -Cyclopropyl"7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^0'^)bis (acyloxy-O)borate<br>
-	Isolation and drying of (4aS-Cis)-1-Cyclopropyl-7-(2,8-diazabicyclo [4.3.0] non-8-Yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0 ,0'^)bis (acyloxy-O)borate<br>
The        prepared        1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis (acyloxy-O)borate is a hydrate. The novel<br><br>
intermediate (4aS-Cis)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0lnon-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0 ,0'*)bis (acyloxy-0)borate is aniiydrous. Tiiese compounds are ciiaracterized by chemical analysis, NMR, FTIR and XRD analysis data.<br>
The starting materials Ethyl 1-cyclopropyl-6,7"difluoro-8-methoxy-4-oxO"1,4-dihydro-3-quinoline carboxylate and [S,S]-2,8-Diaza bicyclo[4.3.0]nonane are prepared by literature reported methods.<br>
Acetic anhydride is heated to about 70^C, and boric acid is added in lots. The reaction mass is stirred for about 1hr to about 2 hrs at temperatures of about 70^C - about 125^C, preferably at about 110^C to - about 120^C, cooled to temperature of about 60*^C - about 100*^C, preferably to about 70*^0. To this mixture, ethyl(1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylate is added, the temperature raised to about 90^C - about 120^C, preferably to about 100^C - about 110^C and mixed for about 1hr to about 5 hrs preferably for about 1 hr. The reaction mass is cooled to temperature below 35*^C, preferably to about O^C - about 20^C, preferably to about O^C followed by addition of cold water and then mixed for about 1 to about 4 hrs. The product formed is separated by conventional means, washed with water and dried to obtain 1-Cyclopropyl-6, 7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis (acyloxy-O)borate.<br>
(1-Cyclopropyl-6, 7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-O^.C^jbis (acyloxy-O)borate is suspended in organic polar solvents preferably DMSO, DMF, acetonitrile, ethanol and mixed with [S,S]-2,8-diaza bicyclo[4.3.0]nonane in presence of organic, inorganic base(s) preferably triethyl amine, DBU, diisopropvl ethyl amine, potassium carbonate at temperatures about 20^C - about 120X, preferably at about 60*^C - about 80^C for about 1 hr to 6 hrs. After the completion of reaction the reaction mass is cooled and the novel intermediate (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-O^.O'^jbis (acyloxy-O)borate is separated by removal of solvent under vacuum below 60 C preferably at about 40^C - 45*^C followed by addition of the hydrocarbons preferably hexane, heptane, cyclohexane, methyl cyclohexane and mixed for about 2 hrs the product is filtered and dried.<br><br>
The invention is now illustrated with a few non-limiting examples.<br>
EXAMPLE-I<br>
Stage-1<br>
Acetic anhydride (175 gms) is heated to 70oC and boric acid (30 gms) is slowly added lot wise in a temperature range of about 70oC to about 90oC. The temperature is then raised, maintained under reflux for 1 hr followed by cooling to about 70oC. Ethyl 1 -cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylate (100 gms ) is added under stirring. The temperature is then raised and maintained for 1 hr in the range of about l00oC to 105oC. The reaction mass is cooled to 0*oC, chilled water (400 ml) is added slowly followed by cold water (600 ml) at temperature 0*oC to 5*oC and maintained for 2 hrs at about OoC to about 5oC. The product which is a boron acetate complex is filtered, washed with water (500 ml) and dried at about 55°C to about 60°C under vacuum to constant weight.<br>
The dry wt is 130.0 gms corresponding to yield of 95.2%<br>
Stage - 2 :<br>
The boron acetate complex (130 gms) prepared in stage-1 is suspended in acetonitrile (650 ml), and [S,S]-2,8-Diazabicyclo[4.3.0]nonane (47 gms) and triethyl amine (72.9 gms) are added. The temperature is raised to reflux and maintained for 1 hr. at reflux, followed by cooling to about 40oC. The solvent is removed under vacuum at temperature below 40*oC, and n-hexane (200 ml) is added. After maintaining the reaction mass for 1 hr at room temperature the product is isolated by filtration followed by washing of the wet cake with n-hexane. The product is dried at about 45oC to about 50*oC to constant weight. Dry wt of the novel intermediate is 117.0 gms corresponding to yield of 71.5%.<br>
Elemental analysis: C: 56.42%, H: 5.62%, N: 7.76% and calculated values for the intermediate formula is C25H29BFN3O8 C: 56.6%, H: 5.47%, N: 7.92%<br>
IR Spectrum (KBr,cm-^): 3415,3332,2936, 1718, 1630, 1573, 1526, 1445, 1273, 1042, 935, 860, 798, 682<br>
^HNMR(200MHz. CDCI3, ppm): 9.00 (1H), 7.82 (1H), 4.12 (4H), 3,57 (3H), 3.43 (4H), 3.07 (2H), 2.75 (2H), 2.4 (1H), 2.1 (6H), 1.84 (2H), 1.6 (1H), 1.31   (2H)<br>
Mass Spectrum (M^): 530.3 [M^H], 470.2 [M^ - CH3COOH], 428.2 [M^-(CH3CO)20, 100%], 402.2, 388.2<br><br><br><br><br>
Claims:<br>
We claim<br>
1.	A process for the preparation of a novel intermediate (4aS-Cis)-1-<br>
Cyclopropyl-7-(2,8 diazabicyclo[4.3.0lnon-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-<br>
dihydro-3-quinoline carboxylic acid-0 ,0'^)bis (acyloxy-O)borate comprising:<br>
-	Reaction of ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylate with a mixture of boric acid and acetic anhydride   at temperature above 50oC without the use of catalyst<br>
-	Separation of (1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-O3O4jbis (acyloxy-O)borate by cooling to low temperature followed by dilution with water<br><br>
-	Isolation and drying of the (1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'*)bis (acyloxy-O)borate<br>
-	Condensation of (1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'*)bis (acyloxy-O)borate with (S,S)-2,8-Diazabicyclo[4.3.0]nonane in presence of base(s) in organic polar solvent(s)<br>
-	Crystallizat of (4aS-Cis)-1 -cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'*)bis (acyloxy-O)borate<br>
-	Isolation    and    drying    of    (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo [4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis (acyloxy-O)borate<br>
2.	A process as claimed in claim 1, wherein the temperature for the reaction<br>
of ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylate with the mixture of boric acid and acetic anhydride is in the range of about 90^C to about 120^C.<br>
3.	A process as claimed in claim 1, wherein the organic polar solvents are<br>
acetonitrile, DMSO, DMF.^<br>
4.	A process as claimed in claims 1-3, wherein the base(s) used is organic or inorganic bases<br>
5.	A process as claimed in claims 1 &amp; 4 wherein the organic base(s) is triethyl amine, di isopropyl ethylamine, DBU<br><br>
6.	A process as claimed in claims 1 &amp; 5 wherein the inorganic base is potassium<br>
carbonate<br>
7.	A process as claimed in claim 1, wherein the temperature for the condesation reaction is in the range of about 30oC to about 100oC, preferably from about 60oC to about 80°C<br>
8.	A process as claimed in claim 1, wherein the crystallization of (4aS-Cis)-1-Cyclopropyl-7-(2,8-diazabicyclo [4.3.0]non-8-yl)-6-fluoro-8-methoxy -4-oxo-1,4-dihydro-3-quinoline carboxylic acid-O^.C^jbis (acyloxy-O)borate is carried out by removal of solvent and addition of a second solvent<br>
9.	A process as claimed in claims 1&amp; 8 wherein the second solvent is selected<br>
from hydrocarbons of C-5 to C-7<br>
10.	A process as claimed in claims 1,8 &amp; 9 wherein the hydrocarbon is alkyl,<br>
cycloalkyi or mixtures thereof<br>
11.	A process as claimed in claims 1,8,9 &amp; 10 wherein the hydrocarbon is n-<br>
hexane, n-heptane, cyclohexane, methyl cyclohexane or mixtures thereof<br>
12.	A process as claimed in claim 1, wherein the intermediate (4aS-Cis)-1-<br>
Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-<br>
1,4-dihydro-3-quinoline   carboxylic   acid-0 ,0'^)bis   (acyloxy-O)borate   is<br>
isolated or without isolation processed for the preparation of moxifloxacin or<br>
its salts or hydrates<br>
13.	The compound (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-<br>
8-yl)-6-fluorO"8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis(acyloxy-0)-borate<br><br><br>
The present invention relates to a method for the preparation of novel intermediate (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0Jnon-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0 ,0'*)bis (acyloxy-0)borate by the reaction of ethyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylate with boric acid and acetic anhydride without using any catalyst gives (1-Cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0^)bis (acyloxy-O)borate which upon condensation in presence of a base(s) with (S,S)-2,8-diazabicyclo[4.3.0]nonane in organic polar solvent results the novel intermediate (4aS-Cis)-1-cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinoline carboxylic acid-0^,0'^)bis (acyloxy-O)borate.<br></td>
			</tr>
		</table>	
		<br>
		<h3>Documents:</h3>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWFic3RyYWN0LnBkZg==" target="_blank" style="word-wrap:break-word;">638-che-2003-abstract.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWNsYWltcyBkdXBsaWNhdGUucGRm" target="_blank" style="word-wrap:break-word;">638-che-2003-claims duplicate.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWNsYWltcyBvcmlnaW5hbC5wZGY=" target="_blank" style="word-wrap:break-word;">638-che-2003-claims original.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWNvcnJlc3BvbmRuZWNlLW90aGVycy5wZGY=" target="_blank" style="word-wrap:break-word;">638-che-2003-correspondnece-others.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWNvcnJlc3BvbmRuZWNlLXBvLnBkZg==" target="_blank" style="word-wrap:break-word;">638-che-2003-correspondnece-po.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWRlc2NyaXB0aW9uKGNvbXBsZXRlKSBkdXBsaWNhdGUucGRm" target="_blank" style="word-wrap:break-word;">638-che-2003-description(complete) duplicate.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWRlc2NyaXB0aW9uKGNvbXBsZXRlKSBvcmlnaW5hbC5wZGY=" target="_blank" style="word-wrap:break-word;">638-che-2003-description(complete) original.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWRyYXdpbmdzLnBkZg==" target="_blank" style="word-wrap:break-word;">638-che-2003-drawings.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWZvcm0gMS5wZGY=" target="_blank" style="word-wrap:break-word;">638-che-2003-form 1.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWZvcm0gMTkucGRm" target="_blank" style="word-wrap:break-word;">638-che-2003-form 19.pdf</a></p>
				<p><a href="http://ipindiaonline.gov.in/patentsearch/GrantedSearch/pdfviewer.aspx?AppNo=NjM4LWNoZS0yMDAzLWZvcm0gMy5wZGY=" target="_blank" style="word-wrap:break-word;">638-che-2003-form 3.pdf</a></p>
		<br>
		<div class="pull-left">
			<a href="202961-a-novel-process-for-the-preparation-and-purification-of-recombinant-proteins.html">&laquo; Previous Patent</a>
		</div>
		<div class="pull-right">
			<a href="202963-a-fuel-injection-control-apparatus-for-an-internal-combustion-engine.html">Next Patent &raquo;</a>
		</div>			
	</div><!-- /span8 -->
	<div class="span4">
		<div class="well infobox">
			<table class="table table-condensed">
				<tr>
					<th>Patent Number</th>
					<td>202962</td>
				</tr>
				<tr>
					<th>Indian Patent Application Number</th>
					<td>638/CHE/2003</td>
				</tr>
				<tr>
					<th>PG Journal Number</th>
					<td>05/2007</td>
				</tr>
				<tr>
					<th>Publication Date</th>
					<td>02-Feb-2007</td>
				</tr>
				<tr>
					<th>Grant Date</th>
					<td>06-Nov-2006</td>
				</tr>
				<tr>
					<th>Date of Filing</th>
					<td>05-Aug-2003</td>
				</tr>
				<tr>
					<th>Name of Patentee</th>
					<td>M/S. MATRIX LABORATORIES LTD</td>
				</tr>
				<tr>
					<th>Applicant Address</th>
					<td>1-1-151/1, IV FLOOR, SAIRAM TOWERS, ALEXANDER ROAD, SECUNDRABAD 500 003.</td>
				</tr>
				<tr>
					<td colspan=2>
								<h5>Inventors:</h5>
								<table class="table">
									<tr>
										<th>#</th>
										<th>Inventor's Name</th>
										<th>Inventor's Address</th>
									</tr>

										<tr>
											<td>1</td>
											<td>DR. CHAVA SATYANARAYANA</td>
											<td>PLOT NO 40, PARKVIEW ENCLAVE MANOVIKAS NAGAR, HASAMATHPET ROAD, SECUNDERABAD-500 009.</td>
										</tr>
										<tr>
											<td>2</td>
											<td>DR. GORANTLA SEETA RAMANJANEYULU</td>
											<td>PLOT NO-10, SAI ANSH ARCADE DURGAVIHAR COLONY, TIRUMALGHERRY, SECUNDERABAD-500 015, INDIA.</td>
										</tr>
										<tr>
											<td>3</td>
											<td>MR. DAMMALAPATI VENKATA LAKSHMI NARASIMHARAO</td>
											<td>201, SHOBHANA TOWERS, ROAD NO-3 VIVEKANANDA NAGAR COLONY, KUKATPALLY HYDERABAD-500 072.</td>
										</tr>
										<tr>
											<td>4</td>
											<td>DR. VASIREDDI UMAMAHESWARA RAO</td>
											<td>101, RUKMINI APARTMENTS, YUSUFGUDA CHECKPOST HYDERABAD-500 045, INDIA.</td>
										</tr>
								</table>
					</td>
				</tr>
				<tr>
					<th>PCT International Classification Number</th>
					<td>A61K 31/69</td>
				</tr>
				<tr>
					<th>PCT International Application Number</th>
					<td>N/A</td>
				</tr>
				<tr>
					<th>PCT International Filing date</th>
					<td></td>
				</tr>
				<tr>
					<td colspan=2>
						<h5>PCT Conventions:</h5>
						<table class="table">
							<tr>
								<th>#</th>
								<th>PCT Application Number</th>
								<th>Date of Convention</th>
								<th>Priority Country</th>
							</tr>

								<tr>
									<td>1</td>
									<td></td>
									<td></td>
								    <td>NA</td>
								</tr>

						</table>
					</td>
				</tr>
			</table>
		</div><!-- /well -->
	</div><!-- /span4 -->
</div><!-- /row-fluid -->

        </div>

      </div><!--/row-->

      <footer class="footer">

        <style>
        .allindianpatents-footer { width: 320px; height: 50px; }
        @media(min-width: 500px) { .allindianpatents-footer { width: 468px; height: 60px; } }
        @media(min-width: 800px) { .allindianpatents-footer { width: 728px; height: 90px; } }
        </style>
        <center>
        </center>

        <p>&copy; All Indian Patents, 2013-2021.</p>
        <p>Patent data available in the public domain from Indian Patents Office, Department of Industrial Policy and Promotions, Ministry of Commerce and Industry, Government of India.</p>
      </footer>

    </div> <!-- /container -->

    <!-- Javascripts
    ================================================== -->
    <!-- Placed at the end of the document so the pages load faster -->
    <script src="../assets/application-95f297ff0d8d2015987f04b30593c800.js" type="text/javascript"></script>

    <!-- Start of StatCounter Code for Default Guide -->
    <script type="text/javascript">
    var sc_project=8902313; 
    var sc_invisible=1; 
    var sc_security="3c1f8147"; 
    var scJsHost = (("https:" == document.location.protocol) ?
    "https://secure." : "http://www.");
    document.write("<sc"+"ript type='text/javascript' src='" +
    scJsHost+
    "statcounter.com/counter/counter.js'></"+"script>");
    </script>
    <noscript><div class="statcounter"><a title="web stats"
    href="http://statcounter.com/free-web-stats/"
    target="_blank"><img class="statcounter"
    src="http://c.statcounter.com/8902313/0/3c1f8147/1/"
    alt="web stats"></a></div></noscript>
    <!-- End of StatCounter Code for Default Guide -->

    <script>
      (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
      (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
      m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
      })(window,document,'script','http://www.google-analytics.com/analytics.js','ga');

      ga('create', 'UA-244143-31', 'allindianpatents.com');
      ga('send', 'pageview');

    </script>

  </body>

<!-- Mirrored from www.allindianpatents.com/patents/202962-a-process-for-the-preparation-of-novel-intermediate-of-moxifloxacin-therefor-and-production-method-of-the-intermediate by HTTrack Website Copier/3.x [XR&CO'2014], Fri, 05 Apr 2024 02:28:31 GMT -->
</html>
